surmount-1 tirzepatide non-diabetic obesity weight loss 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO trial investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but without diabetes. Researchers Clinical trials of subcutaneous tirzepatide

And so, it takes another step further and it's looking at 11,000 plasma proteins

In addition, studies suggest that asparagus spears have some antimicrobial properties, which may help protect against certain infections

Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al

Sources Koenig, W., Sund, M., Frhlich, M., Fischer, H

Improving your nightly routine may also help you avoid bags under your eyes

Introducing Healthletic's BPC-157: A Closer Look A Clean, Oral Peptide Formulation for Modern Needs Healthletic's BPC-157 is designed for individuals seeking a trusted, high-quality peptide supplement that fits easily into a daily wellness routine